Characterization of Bone Lesions in Myeloma Before and During Anticancer Therapy Using 18F-FDG-PET/CT and 18F-NaF-PET/CT

Thomas Selim Nakuz, Filipe Portela Millinger, Karem El-Rabadi, Michael Weber, Verena Pichler, Wolfgang Wadsak, Markus Mitterhauser, Alexander Haug, Marcus Hacker, Georgios Karanikas, Peter Pietschmann, Hermine Agis

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)1943-1952
Number of pages10
JournalAnticancer Research
Volume39
Issue number4
DOIs
Publication statusPublished - Apr 2019
Externally publishedYes

Austrian Fields of Science 2012

  • 302054 Nuclear medicine

Keywords

  • Adult
  • Aged
  • Bone Density
  • Female
  • Fluorodeoxyglucose F18/administration & dosage
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma/complications
  • Osteolysis/diagnostic imaging
  • Positron Emission Tomography Computed Tomography
  • Predictive Value of Tests
  • Radiopharmaceuticals/administration & dosage
  • Retrospective Studies
  • Sodium Fluoride/administration & dosage
  • Time Factors
  • Treatment Outcome
  • STATEMENT
  • positron-emission tomography
  • FDG PET/CT
  • F-18-FLUORIDE
  • F-18-FDG
  • CRITERIA
  • MULTIPLE-MYELOMA
  • DIAGNOSIS
  • multiple myeloma
  • POSITRON-EMISSION-TOMOGRAPHY
  • DISEASE
  • PET/CT
  • F-18-sodium fluoride
  • PET
  • Positron-emission tomography
  • Multiple myeloma
  • F-sodium fluoride
  • F-FDG

Cite this